| Renal sympathetic-nerve ablation for uncontrolled hypertension MP Schlaich, PA Sobotka, H Krum, E Lambert, MD Esler New England Journal of Medicine 361 (9), 932-934, 2009 | 1270 | 2009 |
| Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation MP Schlaich, E Lambert, DM Kaye, Z Krozowski, DJ Campbell, G Lambert, ... Hypertension 43 (2), 169-175, 2004 | 795 | 2004 |
| Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy MP Schlaich, DM Kaye, E Lambert, M Sommerville, F Socratous, MD Esler Circulation 108 (5), 560-565, 2003 | 709 | 2003 |
| Sympathetic activation in chronic renal failure MP Schlaich, F Socratous, S Hennebry, N Eikelis, EA Lambert, ... Journal of the American Society of Nephrology 20 (5), 933-939, 2009 | 571 | 2009 |
| Mechanisms of sympathetic activation in obesity-related hypertension M Esler, N Straznicky, N Eikelis, K Masuo, G Lambert, E Lambert Hypertension 48 (5), 787-796, 2006 | 549 | 2006 |
| Renal denervation in moderate to severe CKD D Hering, F Mahfoud, AS Walton, H Krum, GW Lambert, EA Lambert, ... Journal of the American Society of Nephrology 23 (7), 1250-1257, 2012 | 481 | 2012 |
| Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension D Hering, EA Lambert, P Marusic, AS Walton, H Krum, GW Lambert, ... Hypertension 61 (2), 457-464, 2013 | 426 | 2013 |
| Sympathetic nervous activation in obesity and the metabolic syndrome—causes, consequences and therapeutic implications GW Lambert, NE Straznicky, EA Lambert, JB Dixon, MP Schlaich Pharmacology & therapeutics 126 (2), 159-172, 2010 | 424 | 2010 |
| Sympathetic activity in major depressive disorder: identifying those at increased cardiac risk? DA Barton, T Dawood, EA Lambert, MD Esler, D Haikerwal, C Brenchley, ... Journal of hypertension 25 (10), 2117-2124, 2007 | 347 | 2007 |
| Critical review of transcutaneous vagus nerve stimulation: challenges for translation to clinical practice JYY Yap, C Keatch, E Lambert, W Woods, PR Stoddart, T Kameneva Frontiers in neuroscience 14, 284, 2020 | 338 | 2020 |
| Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome NE Straznicky, EA Lambert, GW Lambert, K Masuo, MD Esler, PJ Nestel The Journal of Clinical Endocrinology & Metabolism 90 (11), 5998-6005, 2005 | 309 | 2005 |
| Elevated brain serotonin turnover in patients with depression: effect of genotype and therapy DA Barton, MD Esler, T Dawood, EA Lambert, D Haikerwal, C Brenchley, ... Archives of General Psychiatry 65 (1), 38-46, 2008 | 278 | 2008 |
| Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes JB Dixon, LM Chuang, K Chong, SC Chen, GW Lambert, NE Straznicky, ... Diabetes care 36 (1), 20-26, 2013 | 256 | 2013 |
| Chronic mental stress is a cause of essential hypertension: presence of biological markers of stress M Esler, N Eikelis, M Schlaich, G Lambert, M Alvarenga, T Dawood, ... Clinical and Experimental Pharmacology and Physiology 35 (4), 498-502, 2008 | 253 | 2008 |
| Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults E Lambert, CI Sari, T Dawood, J Nguyen, M McGrane, N Eikelis, ... Hypertension 56 (3), 351-358, 2010 | 247 | 2010 |
| Differing pattern of sympathoexcitation in normal-weight and obesity-related hypertension E Lambert, N Straznicky, M Schlaich, M Esler, T Dawood, E Hotchkin, ... Hypertension 50 (5), 862-868, 2007 | 240 | 2007 |
| Renal denervation: a potential new treatment modality for polycystic ovary syndrome? MP Schlaich, N Straznicky, M Grima, C Ika-Sari, T Dawood, F Mahfoud, ... Journal of hypertension 29 (5), 991-996, 2011 | 239 | 2011 |
| Inter‐related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS S Shorakae, S Ranasinha, S Abell, G Lambert, E Lambert, B de Courten, ... Clinical endocrinology 89 (5), 628-633, 2018 | 185 | 2018 |
| Metabolic syndrome: a sympathetic disease? M Schlaich, N Straznicky, E Lambert, G Lambert The lancet Diabetes & endocrinology 3 (2), 148-157, 2015 | 178 | 2015 |
| Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease MP Schlaich, B Bart, D Hering, A Walton, P Marusic, F Mahfoud, M Böhm, ... International journal of cardiology 168 (3), 2214-2220, 2013 | 172 | 2013 |
Gavin LambertSwinburne University of TechnologyEmail verificata su swin.edu.au
